Phathom Pharmaceuticals Stock Quote PHAT - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

11.52

Bid

11.52

Ask

152.00

Volume

861,506

11.10 Day's Range 11.83

6.065 52 Week Range 17.0185

Market Cap

674.325M

Previous Close

11.28

Open

11.49

Last Trade

11.7

Last Trade Time

Financial Volume

$ 9,994,571

VWAP

11.6013

Average Volume (3m)

643,202

Shares Outstanding

58,535,193

Dividend Yield

PE Ratio

-3.41

Earnings Per Share (EPS)

-3.44

Revenue

682k

Net Profit

-201.59M

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small molecule potassium competitive acid blocker medicine that ... Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.phathompharma.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Phathom Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker PHAT. The last closing price for Phathom Pharmaceuticals was $11.28. Over the last year, Phathom Pharmaceuticals shares have traded in a share price range of $ 6.065 to $ 17.0185.

Phathom Pharmaceuticals currently has 58,535,193 shares outstanding. The market capitalization of Phathom Pharmaceuticals is $660.28 million. Phathom Pharmaceuticals has a price to earnings ratio (PE ratio) of -3.41.

Form 8-K - Current report

Phathom Pharmaceuticals Announces FDA Approval of VOQUEZNA® (vonoprazan) Tablets for the Relief of Heartburn Associated with Non-Erosive GERD in Adults

VOQUEZNA is now approved and available to treat the largest category of Gastroesophageal Reflux Disease (GERD)VOQUEZNA met its primary endpoint in its Phase 3 pivotal trial by demonstrating a...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.23	2.03720106289	11.29	12.44	10.76	814133	11.5596086	CS
4	1	9.50570342205	10.52	12.9899	9.8175	865185	11.32735141	CS
12	1.17	11.3043478261	10.35	12.9899	9.23	643202	10.87199584	CS
26	4.33	60.2225312935	7.19	12.9899	6.065	756871	10.01647293	CS
52	-2.22	-16.1572052402	13.74	17.0185	6.065	614915	9.92296429	CS
156	-21.09	-64.6734130635	32.61	37.17	5.84	368380	10.99178037	CS
260	-12.795	-52.6218383714	24.315	64.54	5.84	266688	14.30765282	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
WINTWindtree Therapeutics Inc	$ 8.24 (150.46%)	48.57M
BFIBurgerFi International Inc	$ 0.4206 (97.37%)	313.59M
NBSTWNewbury Street Acquisition Corporation	$ 0.1349 (92.71%)	122.1k
YIBOPlanet Image International Ltd	$ 2.915 (53.43%)	260.07k
CREVCarbon Revolution Public Ltd	$ 9.00 (45.87%)	8.06M
NMHINatures Miracle Holding Inc	$ 0.2035 (-48.06%)	7.69M
TANHTantech Holdings Ltd	$ 0.2585 (-47.23%)	6.75M
DXCMDexCom Inc	$ 64.00 (-40.66%)	53.92M
PSIGPS International Group Ltd	$ 1.42 (-31.40%)	716.26k
POAIPredictive Oncology Inc	$ 1.36 (-27.27%)	6.02M
SLNASelina Hospitality PLC	$ 0.0305 (-18.88%)	408.61M
BFIBurgerFi International Inc	$ 0.4206 (97.37%)	313.59M
NVDANVIDIA Corporation	$ 113.06 (0.69%)	293.33M
SQQQProShares UltraPro Short QQQ	$ 9.10 (-2.88%)	176.49M
SGMOSangamo Therapeutics Inc	$ 0.8612 (28.15%)	123.71M